Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Heyman

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Cancers|February 10, 2019
Chimeric Antigen Receptor T Cell Therapy for Solid Tumors: Current Status, Obstacles and Future StrategiesBenjamin Heyman, Yiping Yang
Experimental Hematology|August 31, 2016
Mechanisms of heparanase inhibitors in cancer therapyBenjamin Heyman, Yiping Yang
Cancers|March 28, 2025
Updates on the Treatment of Richter's Syndrome, Including Novel Combination ApproachesTanim Jain, Benjamin Heyman
The EMBO Journal|October 22, 2019
To PARP or not to PARP?-Toward sensitizing acute myeloid leukemia stem cells to immunotherapyBenjamin Heyman, Catriona Jamieson
Cancer Biology & Medicine|September 11, 2018
New developments in immunotherapy for lymphomaBenjamin Heyman, Yiping Yang
Cancers|April 5, 2020
Chimeric Antigen Receptor Cell Therapy: Overcoming Obstacles to Battle CancerAmy J Petty, Benjamin Heyman, Yiping Yang
Ejhaem|June 27, 2025
Venetoclax Consolidation After Bruton Tyrosine Kinase Inhibitor Treatment for Patients With Chronic Lymphocytic LeukemiaBenjamin Heyman, Michael Choi, Thomas J Kipps
Case Reports in Hematology|March 4, 2024
A + AVD for Treatment of Hodgkin Lymphoma Variant of Richter's TransformationBenjamin Heyman, Michael Choi, Thomas J Kipps
Case Reports in Hematology|August 31, 2019
Durable Control of Mycosis Fungoides after Sepsis: "Coley's Toxin?" Case Report and Review of the LiteratureBenjamin Heyman, Chris R Kelsey, Anne Beaven
Ejhaem|June 22, 2026
Comparison of Venetoclax-Based Treatments for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia: A Single-Center Real-World ExperienceBenjamin Heyman, Michael Choi, Thomas J Kipps
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cancers|February 10, 2019
Chimeric Antigen Receptor T Cell Therapy for Solid Tumors: Current Status, Obstacles and Future StrategiesBenjamin Heyman, Yiping Yang
Experimental Hematology|August 31, 2016
Mechanisms of heparanase inhibitors in cancer therapyBenjamin Heyman, Yiping Yang
Cancers|March 28, 2025
Updates on the Treatment of Richter's Syndrome, Including Novel Combination ApproachesTanim Jain, Benjamin Heyman
The EMBO Journal|October 22, 2019
To PARP or not to PARP?-Toward sensitizing acute myeloid leukemia stem cells to immunotherapyBenjamin Heyman, Catriona Jamieson
Cancer Biology & Medicine|September 11, 2018
New developments in immunotherapy for lymphomaBenjamin Heyman, Yiping Yang
Cancers|April 5, 2020
Chimeric Antigen Receptor Cell Therapy: Overcoming Obstacles to Battle CancerAmy J Petty, Benjamin Heyman, Yiping Yang
Ejhaem|June 27, 2025
Venetoclax Consolidation After Bruton Tyrosine Kinase Inhibitor Treatment for Patients With Chronic Lymphocytic LeukemiaBenjamin Heyman, Michael Choi, Thomas J Kipps
Case Reports in Hematology|March 4, 2024
A + AVD for Treatment of Hodgkin Lymphoma Variant of Richter's TransformationBenjamin Heyman, Michael Choi, Thomas J Kipps
Case Reports in Hematology|August 31, 2019
Durable Control of Mycosis Fungoides after Sepsis: "Coley's Toxin?" Case Report and Review of the LiteratureBenjamin Heyman, Chris R Kelsey, Anne Beaven
Ejhaem|June 22, 2026
Comparison of Venetoclax-Based Treatments for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia: A Single-Center Real-World ExperienceBenjamin Heyman, Michael Choi, Thomas J Kipps
Pageof 2